Introduction Arterial remodelling and stiffening have been demonstrated in endstage renal disease (ESRD). The presence of vascular alterations in earlier-stage chronic kidney disease (CKD) is less studied. We evaluated vascular structure and function in mild-to-moderate CKD (stages 2-3) compared with healthy subjects and advanced CKD (stages 4-5). Methods Carotid ultrasound was performed in 103 non-dialysis CKD patients and 54 healthy controls. Carotid intima-media thickness (CIMT) and common carotid artery (CCA) diameter were measured. Strain, stiffness and the pressure-strain elastic modulus (E p ) of the right CCA were calculated. Results There was no significant difference in CCA diameter between CKD 2-3 and controls. The CCA diameter was larger in CKD 4-5 compared with CKD 2-3 and controls (CKD 4-5, 6Á50 AE 0Á79 mm versus CKD 2-3, 6Á08 AE 0Á56 mm, P = 0Á003; and versus controls 5Á97 AE 0Á53 mm, P<0Á001). However, after adjustments, the difference in CCA diameter was valid only for older ages and also dependent on systolic blood pressure (SBP). There were no significant differences in CIMT, strain or stiffness between the groups, but E p was higher in CKD 4-5 compared with controls (P = 0Á006). Conclusion In mild-to-moderate CKD, there were no significant differences in carotid artery structure or function compared with healthy subjects. Only patients with advanced CKD and older ages showed signs of arterial remodelling. Our study indicates that vascular alterations occur in advanced CKD, with SBP and age as important contributing factors.
Introduction
Chronic kidney disease (CKD) is strongly associated with an increased risk of cardiovascular (CV) disease (CVD) and allcause mortality (Foley et al., 1998; Go et al., 2004) . Vascular calcification, arterial stiffness and remodelling are major complications of CKD that were until recently described mainly in end-stage renal disease (ESRD) (Blacher et al., 2001; London et al., 2002 London et al., , 2013 .
Increased carotid intima-media thickness (CIMT), a predictor of adverse CV events in the general population (Lorenz et al., 2007) , has also been shown to be an independent predictor of CV mortality in dialysis patients (Benedetto et al., 2001) . In CKD patients not on dialysis, CIMT has been reported to be a predictor of CVD (Szeto et al., 2007; Matsushita et al., 2015) .
The increased arterial stiffness in CKD is associated with an isolated increase in systolic blood pressure (SBP), structural and functional cardiac abnormalities and is an independent predictor of overall and CV mortality in ESRD (Blacher et al., 2001; London et al., 2002; Chue et al., 2010) .
In recent years, vascular calcification, arterial remodelling and increased arterial stiffness have been described also in earlier stages of CKD (Briet et al., 2006; Hermans et al., 2007; Briet & Burns, 2012; Claridge et al., 2015) , and an increased carotid diameter and aortic stiffness have been reported to be independent predictors of mortality in mild-to-moderate CKD (Karras et al., 2012) . However, the results are inconsistent.
The specific aim of this study was to evaluate carotid artery structure and function in mild-to-moderate CKD (stages 2-3) and compare it with that in healthy controls and in patients with advanced CKD (stages 4-5).
Methods Patients and control subjects
The patients and healthy controls were included in a prospective single-centre observational cohort study, PROGRESS 2002, which was described in detail previously (Asp et al., 2015) . Briefly, 103 Swedish-speaking CKD patients not on dialysis, 18-65 years of age, and 54 controls were included. Consecutive patients were recruited from the outpatient clinic at the Department of Nephrology at the Karolinska University Hospital during 2002-2009 if they had renal function corresponding to CKD stages 2-3 (mild-to-moderate renal dysfunction) or stages 4-5 (severe renal dysfunction) as defined by the National Kidney Foundation (National Kidney Foundation, 2002). As previously described, the CKD patients were divided into two groups according to glomerular filtration rate (GFR) measured by iohexol plasma clearance (Krutz en et al., 1984) : 49 predialysis patients with stages 4-5 CKD (GFR 15Á3 AE 3Á9 ml min À1 1Á73 m
À2
) and 54 patients with stages 2-3 CKD (GFR 60Á1 AE 5Á2 ml min À1 1Á73 m
). Fifty-four healthy controls (GFR 99Á3 AE 12Á0 ml min À1 1Á73 m
) matched for age and sex with the stages 2-3 CKD group were also recruited. The controls underwent an interview concerning their health history and medication, to exclude history of kidney disease, CVD, diabetes or any ongoing medication. Exclusion criteria for all participants were as follows: known current malignancy, kidney transplantation, kidney donation or a blood-transmitted disease.
After inclusion, all participants underwent clinical investigation, laboratory testing and carotid ultrasound examination. In this study, we have analysed the baseline data.
The study protocol was reviewed and approved by the Local Ethics Committee and Institutional Review Board of the Karolinska Institutet at the Karolinska University Hospital, and all participants gave their written informed consent.
Carotid ultrasound
All carotid ultrasound examinations were performed with the subject supine by two experienced sonographers using an ultrasound machine (Sequoia 512, Siemens Medical Solutions, Mountain View, CA, USA), equipped with a 5-to 8-MHz multifrequency linear array transducer. The ultrasound images were stored digitally on magneto-optical discs and on an EchoPAC server (Image Vault 5.0 system, General Electric Company, Horten, Norway).
The examinations included measurements of the diameter and CIMT of the left and right common carotid artery (CCA) and calculations of arterial stiffness according to a standardized protocol, as described previously (Jensen-Urstad & Rosfors, 1997) . All measurements were made from the B-mode and M-mode images on the ultrasound machine after the ultrasound scan was completed.
To measure CCA diameter and wall thickness, the CCA just proximal to the bulb was visualized in the longitudinal plane. The CCA images were taken in B-mode and frozen concurrently with the R wave on the electrocardiogram. The CCA diameter was measured from the leading edge of the near-wall echogenic intima-media (IM) line to the leading edge of the luminal echo of the far wall. CIMT was measured in the far wall of the CCA and defined as the distance between the leading edge of the luminal echo and the leading edge of the media/adventitia echo. CIMT was measured as the mean thickness over a length of 1 cm just proximal to the bulb, using the trace function of the ultrasound machine. CCA diameter and CIMT were measured separately for left and right CCA and calculated as average values; both the separate values and the average values were used for calculations of the IM area in the equation below, for each side and as average value, separately.
The IM area was calculated according to the formula (Jogestrand et al., 1996) :
M-mode recording of the right CCA just proximal to the bulb in the longitudinal plane was obtained for measurements of the systolic and diastolic CCA diameters used for calculations of strain, stiffness and the pressure strain elastic modulus (E p ). The M-mode cursor was placed perpendicular to the vessel walls, guided by B-mode. CCA diameters were measured from the leading edge of the echogenic near-wall IM echo to the leading edge of the far wall. Average CCA diameters in systole (D syst ) and diastole (D diast ) were calculated from three consecutive cardiac cycles (Gamble et al., 1994) . Brachial blood pressure (BP) was measured in the right arm with a sphygmomanometer immediately before and after the Mmode scan with subjects in the supine position, and the average systolic and diastolic blood pressures were used in the equations below.
Strain was defined as the amount of deformation in relation to the unstressed state (dimensionless):
Wall stiffness (dimensionless) was calculated according to the formula developed by Kawasaki et al., (1987) , where ln (SBP/DBP) is the natural logarithm of the ratio of SBP and diastolic blood pressure (DBP): Stiffness = ln(SBP/DBP)/ strain. E p , the pressure strain elastic modulus, which is one measure of distensibility, was defined as described by Peterson et al., (1960) : E p = K 9 (SBP À DBP)/strain. K = 133Á3 and is the factor for converting mmHg to N m À2 .
Heart rate was measured in the supine position in the end of the carotid ultrasound examination.
Lipid profiles
Fasting blood samples were collected from the peripheral vein at rest. Lipid profiles were assessed by total cholesterol, high-density lipoprotein cholesterol (HDL) and triglycerides in plasma, determined by enzymatic methods. Low-density lipoprotein cholesterol (LDL) was calculated using the Friedewald formula (Friedewald et al., 1972) .
Statistical analyses
Results are presented as number, percentage, mean and standard deviation (SD), or median and interquartile range, where applicable. Group comparisons were performed using analysis of variance (one-way ANOVA) or Kruskal-Wallis test, when the assumptions of normality and homogeneity were not fulfilled. Group comparisons using one-way ANOVA were followed by Tukey's post hoc test, when appropriate. When Kruskal-Wallis test was used, Bonferroni's post hoc test was performed for adjustment of P values between groups, when appropriate. For categorical variables, chi-square test was used. A P value <0Á05 for a two-tailed test was considered significant.
Potential correlations between variables were analysed using a Pearson correlation test, or using a Spearman correlation test when the correlation seemed to be nonlinear. For CCA diameter, an initial unadjusted analysis was performed comparing CCA diameter between the groups, followed by ANOVA adjusted for the background factors SBP, age, sex, height and smoking (ever). Interaction effects were tested for the product of group and age, sex, height, SBP and smoking, respectively. Statistical analyses were performed using IBM SPSS Statistics for Windows, version 23.0 (IBM, Chicago, IL, USA).
Results
The clinical characteristics of the study participants are summarized in Table 1 . There were no significant differences between the groups in body size or smoking habits. Triglycerides in plasma were higher in the CKD groups compared with the controls. However, LDL was lower in the CKD stages 4-5 group compared with the CKD stages 2-3 group and controls (CKD 4-5 versus CKD 2-3, P = 0Á04; and versus controls, P = 0Á001). The same trend, but not significant, was seen for total cholesterol.
Results from the BP measurements and the ultrasound examination of the CCA are summarized in Table 2 . The CKD 4-5 group, but not the CKD 2-3 group, showed a significant difference in SBP (P<0Á001) and DBP (P = 0Á04) compared with controls.
Measurements of CCA diameter, CIMT and IM area are presented as average values of the left and right CCA. When the sides were studied separately, similar results were obtained. The CCA diameter was significantly larger in the CKD 4-5 group compared with both the CKD 2-3 group and controls (CKD 4-5, 6Á50 AE 0Á79 mm versus CKD 2-3, 6Á08 AE 0Á56 mm, P = 0Á003; and versus controls 5Á97 AE 0Á53 mm, P<0Á001). There was a difference between the groups in the variance of the CCA diameter, with a wider range in the CKD 4-5 group than in the other groups (Levene's test P = 0Á04). However, the significant difference in CCA diameter between the CKD 4-5 group and the other groups remained when a nonparametric test was applied. There were no significant differences in CIMT or IM area between the groups.
Vascular function expressed as strain and stiffness of the CCA did not differ between the groups, but we found significantly higher E p values in CKD 4-5 patients than in controls (P = 0Á006).
In the total cohort, there was a weak negative correlation between CCA diameter and GFR (r = À0Á31, P<0Á001), and a positive correlation between CCA diameter and SBP (r = 0Á63, P<0Á001). When analysing the correlation between CCA diameter and age, a significant linear correlation was found in CKD 4-5 (r = 0Á44, P = 0Á001), but not in the other groups (CKD 2-3, r = 0Á18, P = 0Á19; controls r = 0Á19, P = 0Á16).
Comparing CCA diameter between the groups by adjusted analysis, we used ANOVA adjusted for the background factors age, sex, height, smoking (ever) and SBP. We also assessed the interaction between group and the chosen background factors. In the final model, we adjusted for age, sex, SBP and the interaction between group and age. The adjusted R 2 for the model was 0Á48. In the final model, CCA diameter was dependent on sex (P<0Á001) and SBP (P<0Á001), but the impact of the factor 'group' (with the three categories controls, CKD 2-3 and CKD 4-5) on CCA diameter was not remaining significant (P = 0Á19). However, there was a significant interaction between group and age (P = 0Á03), with a significant effect of age on CCA diameter in CKD 4-5 that could not be found in the other two groups. For CKD 4-5 compared with controls as a reference, the interaction estimate was 0Á02 (P = 0Á02). The interaction estimate should be interpreted as that for group CKD 4-5, for every year the CCA diameter increases with 0Á02 mm (or 0Á2 mm for each 10 year), while no such relation between CCA diameter and age could be seen in the other groups. This means that after adjustments, the difference in CCA diameter between CKD 4-5 and the other groups was only remaining for older ages.
Discussion
In this study, we found no significant difference in CCA diameter between patients with mild-to-moderate CKD and wellcontrolled blood pressure and age-matched healthy controls. Only in patients with advanced CKD, the CCA diameter was significantly larger than in the other groups. In the adjusted analysis with CCA diameter as a dependent variable, there was a significant interaction between group and age, showing that the difference between advanced CKD and the other groups was only valid for older ages. The difference in CCA diameter between the advanced CKD group and the other groups could also partly be explained by a difference in SBP. There were no significant differences in CIMT or IM area between the groups in our study. Analysing the elastic properties of the CCA, we did not find any significant differences in arterial stiffness, strain or E p between patients with mild-to-moderate CKD and controls. However, there was a significant difference in E p between patients with advanced CKD and controls. In hypertensive individuals, an outward hypertrophic remodelling of large arteries has been described (Schiffrin, 2007) . However, in CKD, a phenomenon of maladaptive arterial remodelling characterized by outward remodelling of large arteries identified by an increased arterial diameter not completely compensated for by increased wall thickness has been observed (Briet et al., 2006 (Briet et al., , 2011 Briet & Burns, 2012) . In their study, Briet et al., (2006) demonstrated a larger CCA diameter but no significant difference in CIMT in patients with mild-to-moderate CKD compared with normotensive and hypertensive subjects without CKD. In our study, we found the same pattern, with no difference in CIMT between CKD patients and controls, but a larger CCA diameter in advanced CKD compared with controls. The use of statins in CKD patients and consequently a lower concentration of cholesterol compared with control subjects could be one of the reasons for the similar CIMT in CKD patients and controls. Indeed, both in our study and in the study of Briet et al., the CKD patients showed lower concentrations of cholesterol than the control subjects, probably due to statin use. In our study, only patients with advanced CKD showed a larger CCA diameter than controls. However, the group with mild-to-moderate CKD in our study had a higher mean GFR (60 AE 5 ml min À1 1Á73 m À2 ), compared with the CKD group in their study (36 AE 16 ml min À1 1Á73 m
À2
). Furthermore, in our cohort, we included a younger CKD population (mean age of CKD patients 48 AE 11 years) compared with their study (mean age of CKD patients 58 AE 15 years). In our adjusted analysis, we found that the difference in CCA diameter between advanced CKD and the other groups was only valid for older ages. Therefore, not only the severity of renal dysfunction but also patient age should be considered when comparing results on arterial remodelling in CKD from different studies.
In ESRD patients, carotid arterial stiffness is increased and has been shown to predict all-cause and CV mortality (Blacher et al., Table 1 Characteristics of the study population.
Controls GFR 99Á3
AE 12Á0 (n = 54) CKD 2-3 GFR 60Á1 AE 5Á2 (n = 54) CKD 4-5 GFR 15Á3 AE 3Á9 (n = 49) P value
P value between groups
Age, years
CKD, chronic kidney disease; GFR, glomerular filtration rate; n, number; BMI, body mass index; BSA, body surface area; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; ACE, angiotensin converting enzyme; NA, not analysed. Values reported as number (percentage) or mean AE standard deviation. P value: Analysis of variance (one-way ANOVA) (continuous values) or chi-square (categorical values). P values between groups are indicated as † CKD 2-3 versus controls, 1998, 1999) . However, studies of mild-to-moderate CKD have reported divergent results. It has been reported that arterial stiffness, assessed by pulse wave velocity (PWV), correlated with kidney function decline, with similar PWV values for CKD 1-2 compared with controls, and a stepwise increase in PWV from stage 1 to stage 5 CKD and that estimated GFR and SBP were the major determinants of arterial stiffness in CKD (Wang et al., 2005) . In their analyses of Framingham Heart Study cohorts, Upadhyay et al., (2009) found that arterial stiffness correlated with albuminuria but not with mild-to-moderate CKD. The findings in our study are in line with this, as we did not see any significant association between carotid arterial stiffness and mild-to-moderate CKD. Nevertheless, Hermans et al., (2007) reported that even in subjects with mild renal insufficiency, a lower estimated GFR was found to be associated with greater arterial stiffness. However, that study included an older population (mean age 68 AE 7 years) than our population sample (mean age 48 AE 11 years), which may explain to some extent the differences in the results between the two studies. CIMT measured by carotid ultrasound has been used as a noninvasive surrogate marker for atherosclerosis and is a predictor of CVD (Lorenz et al., 2007; Stein et al., 2008) . However, recently, the additional predictive value of CIMT measurements over the Framingham Risk Score in the general population has been questioned (Den Ruijter et al., 2012) . In our and other studies (Briet et al., 2006 (Briet et al., , 2011 Claridge et al., 2015) , measurements of arterial enlargement and stiffness seem to be more sensitive markers of early CVD in CKD patients and may show change before conventional surrogate markers of CVD such as CIMT. Measurements of arterial stiffness such as pulse pressure and PWV have been suggested to improve risk prediction above that of the Framingham Risk Score in the general population (Berard et al., 2013) and might be of value for risk stratification of CKD patients at different stages of the disease.
The groups in our study are relatively small (around 50 patients per group). Nevertheless, our group of interest (CKD stages 2-3) was age and sex matched to a group of healthy controls, which may make statistical analyses and results more reliable and could be considered a strength of our study. Furthermore, GFR was measured by iohexol, providing an optimal classification of CKD stages. However, we were not able to ascertain the duration of comorbid conditions, such as hypertension and diabetes, which may be considered a limitation of our study. Moreover, at the time of patient inclusion, we had no possibility of assessing PWV for evaluation of arterial stiffness.
Conclusion
In mild-to-moderate CKD, no significant differences in carotid artery structure or function were seen compared with healthy subjects. Only patients with advanced CKD and older ages showed signs of arterial remodelling, with larger CCA diameter than patients with mild-to-moderate CKD and healthy subjects. Furthermore, signs of altered arterial function could be seen only in patients with advanced CKD. Our study indicates that vascular alterations occur when kidney dysfunction is severe, with SBP and age as important contributing factors. This 
